HK1052928A1 - Process for preparing azacycloalkanoylaminothiazoles - Google Patents

Process for preparing azacycloalkanoylaminothiazoles

Info

Publication number
HK1052928A1
HK1052928A1 HK03103394A HK03103394A HK1052928A1 HK 1052928 A1 HK1052928 A1 HK 1052928A1 HK 03103394 A HK03103394 A HK 03103394A HK 03103394 A HK03103394 A HK 03103394A HK 1052928 A1 HK1052928 A1 HK 1052928A1
Authority
HK
Hong Kong
Prior art keywords
sup
aryl
alkyl
heteroaryl
independently hydrogen
Prior art date
Application number
HK03103394A
Other languages
English (en)
Inventor
Bang-Chi Chen
Kyoung S Kim
S David Kimball
Raj N Misra
Mark E Salvati
Joseph E Sundeen
Hai-Yun Xiao
Rulin Zhao
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HK1052928A1 publication Critical patent/HK1052928A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HK03103394A 2000-07-26 2003-05-13 Process for preparing azacycloalkanoylaminothiazoles HK1052928A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61662700A 2000-07-26 2000-07-26
US09/746,060 US6414156B2 (en) 1998-10-21 2000-12-22 Process for preparing azacycloalkanoylaminothiazoles
PCT/US2001/014155 WO2002010163A1 (en) 2000-07-26 2001-05-02 Process for preparing azacycloalkanoylaminothiazoles

Publications (1)

Publication Number Publication Date
HK1052928A1 true HK1052928A1 (en) 2003-10-03

Family

ID=27087817

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03103394A HK1052928A1 (en) 2000-07-26 2003-05-13 Process for preparing azacycloalkanoylaminothiazoles

Country Status (22)

Country Link
US (3) US6414156B2 (da)
EP (1) EP1303514B9 (da)
JP (1) JP2004505080A (da)
KR (1) KR100764949B1 (da)
CN (1) CN1227250C (da)
AT (1) ATE299878T1 (da)
AU (1) AU5936901A (da)
BR (1) BR0112748A (da)
CA (1) CA2417260A1 (da)
CY (1) CY1105666T1 (da)
CZ (1) CZ2003239A3 (da)
DE (1) DE60112091T2 (da)
DK (1) DK1303514T3 (da)
ES (1) ES2245984T3 (da)
HK (1) HK1052928A1 (da)
HU (1) HUP0301649A3 (da)
IL (2) IL153748A0 (da)
LT (1) LT5106B (da)
MX (1) MXPA03000685A (da)
PL (1) PL365464A1 (da)
PT (1) PT1303514E (da)
WO (1) WO2002010163A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262096B1 (en) 1997-11-12 2001-07-17 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
US6414156B2 (en) 1998-10-21 2002-07-02 Bristol-Myers Squibb Company Process for preparing azacycloalkanoylaminothiazoles
US6392053B2 (en) 1999-12-15 2002-05-21 Bristol-Myers Squibb Company Process for preparing arylacetylaminothiazoles
US6534531B2 (en) * 2000-04-27 2003-03-18 Bristol-Myers Squibb Company Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
CA2417254A1 (en) * 2000-07-26 2002-02-07 Bristol Myers Squibb Company N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases
DE10300124A1 (de) * 2003-01-07 2004-07-15 Bayer Ag Verfahren zur Herstellung von Arylalkinen
ATE485300T1 (de) * 2004-07-16 2010-11-15 Sunesis Pharmaceuticals Inc Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
JP2009539846A (ja) * 2006-06-06 2009-11-19 ブリストル−ミエルス スクイッブ カンパニー Ｎ−［５−［［［５−（１，１−ジメチルエチル）−２−オキサゾリル］メチル］チオ］−２−チアゾリル］−４−ピペリジンカルボキサミドの結晶形
TW200922564A (en) * 2007-09-10 2009-06-01 Curis Inc CDK inhibitors containing a zinc binding moiety
WO2010075542A1 (en) 2008-12-23 2010-07-01 Curis, Inc. Cdk inhibitors
EP3384897A1 (de) * 2017-04-03 2018-10-10 Covestro Deutschland AG Kosmetische zusammensetzungen mit speziellen carbodiimiden für haare

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088049A (en) 1975-06-03 1980-10-21 Takashi Masugi 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof
CA1201431A (en) 1981-12-17 1986-03-04 Daiei Tunemoto .beta.-LACTAM COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF
NO831160L (no) 1982-04-08 1983-10-10 Erba Farmitalia Fremstilling av substituerte penem-derivater
JPS6339868A (ja) 1986-08-04 1988-02-20 Otsuka Pharmaceut Factory Inc ジ低級アルキルフエノ−ル誘導体
TW205041B (da) 1989-08-07 1993-05-01 Fujisawa Pharmaceutical Co
DE4119756A1 (de) 1991-06-15 1992-12-17 Basf Ag Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung
US5491157A (en) 1993-05-10 1996-02-13 Eastman Kodak Company Method and composition for the prevention, control and amelioration of soilborne fungi and disease caused thereby
IL112721A0 (en) 1994-03-10 1995-05-26 Zeneca Ltd Azole derivatives
JPH0859669A (ja) 1994-06-13 1996-03-05 Takeda Chem Ind Ltd セフェム化合物、その製造法及び剤
AU4123396A (en) 1994-12-09 1996-06-26 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and pharmaceutical use thereof
IL117620A0 (en) 1995-03-27 1996-07-23 Fujisawa Pharmaceutical Co Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
AUPN801196A0 (en) 1996-02-12 1996-03-07 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and pharmaceutical use thereof
SK5212000A3 (en) 1997-10-27 2001-04-09 Agouron Pharmaceuticals Inc Ag 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
US6040321A (en) 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
US6262096B1 (en) 1997-11-12 2001-07-17 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
US6414156B2 (en) 1998-10-21 2002-07-02 Bristol-Myers Squibb Company Process for preparing azacycloalkanoylaminothiazoles
US6214852B1 (en) 1998-10-21 2001-04-10 Bristol-Myers Squibb Company N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
MY125768A (en) 1999-12-15 2006-08-30 Bristol Myers Squibb Co N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
US6534531B2 (en) 2000-04-27 2003-03-18 Bristol-Myers Squibb Company Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
CA2417254A1 (en) 2000-07-26 2002-02-07 Bristol Myers Squibb Company N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases

Also Published As

Publication number Publication date
CN1227250C (zh) 2005-11-16
DE60112091T2 (de) 2006-04-20
IL153748A (en) 2009-07-20
ES2245984T3 (es) 2006-02-01
US6897321B2 (en) 2005-05-24
PL365464A1 (en) 2005-01-10
IL153748A0 (en) 2003-07-06
CA2417260A1 (en) 2002-02-07
HUP0301649A3 (en) 2008-04-28
BR0112748A (pt) 2003-09-09
JP2004505080A (ja) 2004-02-19
AU5936901A (en) 2002-02-13
KR20030064736A (ko) 2003-08-02
CN1449395A (zh) 2003-10-15
US20040063767A1 (en) 2004-04-01
KR100764949B1 (ko) 2007-10-08
LT2003001A (en) 2003-11-25
HUP0301649A2 (hu) 2003-12-29
DK1303514T3 (da) 2005-10-10
LT5106B (lt) 2004-02-25
ATE299878T1 (de) 2005-08-15
US6639074B2 (en) 2003-10-28
PT1303514E (pt) 2005-11-30
EP1303514B1 (en) 2005-07-20
WO2002010163A1 (en) 2002-02-07
EP1303514B9 (en) 2006-11-08
CZ2003239A3 (cs) 2003-08-13
DE60112091D1 (de) 2005-08-25
US20020099217A1 (en) 2002-07-25
US6414156B2 (en) 2002-07-02
MXPA03000685A (es) 2003-09-10
US20010006976A1 (en) 2001-07-05
EP1303514A1 (en) 2003-04-23
CY1105666T1 (el) 2010-12-22

Similar Documents

Publication Publication Date Title
IL150883A0 (en) Pyrimidine compounds
PL377112A1 (pl) Sposoby wytwarzania związków pirolotriazynowych użytecznych jako inhibitory kinazy
HUP0001507A2 (hu) Pirrolo [2,3-d] pirimidin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
NO20060376L (no) Fremgangsmater for fremstilling av 1-[(benzotmidazol-l-yl)quinolm-8-yl]piperidin-4-ylamin-derivater
CA2161542A1 (en) Novel 5-Pyrrolyl-2-Pyridylmethylsulfinyl Benzimidazole Derivatives
AU5936901A (en) Process for preparing azacycloalkanoylaminothiazoles
NO20022124L (no) Imidazopyridinderivater som fosfodiesterase VII-inhibitorer
WO2002072009A3 (en) Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
WO2001090097A3 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
PL378201A1 (pl) Sposób farmaceutyczny oraz związki wytwarzane tym sposobem
IL153746A0 (en) Process for preparing arylacetylaminothiazole derivatives
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
ES2102295A1 (es) Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
AU2002214320A1 (en) Imidazole derivatives, process for their preparation and their use
HU0201262D0 (da)
DE60002292D1 (de) (3,4-dihydro-2h-benzo[1,4]oxazinyl-methyl)-3-(1h-indol-3-yl)-alkylamine
MXPA06001115A (es) Un proceso nuevo para la preparacion de imipenem.
PL367073A1 (en) Dihydroimidazo [5,1-a]-$g(b)-carboline derivatives, method for preparing same and use thereof as medicine
MXPA03008727A (es) Procedimiento para la preparacion de derivados de imidazol tetrasubstituidos y estructuras cristalinas novedosas de los mismos.
HUT34943A (en) Process for the production of new 1,1-diphenyl-propanol-derivatives, as well as of therapeutic preparations containing them
EP1362853A4 (en) STYRENE DERIVATIVES AND MANUFACTURING METHOD THEREOF

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: CORRECTION OF THE NAME OF APPLICANT/PROPRIETOR FROM BRISTOL-MYERS SQUIBB CO. TO BRISTOL-MYERS SQUIBB COMPANY.

Effective date: 20060612

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100502